When should blood transfusion be performed after split‑thickness skin grafting and what is its purpose?

Blood Transfusion After Split-Thickness Skin Grafting

Blood transfusion after split-thickness skin grafting is NOT routinely indicated and should only be performed when hemoglobin falls below 70 g/L (or 80 g/L in patients with cardiac disease), based on standard transfusion triggers rather than any specific benefit to graft healing. 1

Primary Indication: Treatment of Anemia from Blood Loss

The main reason to transfuse after skin grafting is to correct symptomatic anemia or significant blood loss, not to improve graft take:

• Transfuse when Hb < 70 g/L as the general threshold for red cell transfusion in stable, normovolemic patients 1
• Use Hb < 80 g/L threshold for patients with ischemic heart disease, acute coronary syndrome, or after cardiac surgery 1
• Transfusion is indicated for symptomatic anemia causing shortness of breath, dizziness, congestive heart failure, or decreased exercise tolerance 2
• Consider transfusion for acute blood loss exceeding 30% of blood volume 2

Blood Transfusion Does NOT Improve Graft Take

Critical evidence demonstrates that maintaining higher hemoglobin levels does not enhance skin graft healing:

• A direct study of skin graft take in normovolemic anemic patients (Hb < 10 g/dL) showed no statistically significant difference in mean graft take compared to patients with Hb ≥ 10 g/dL 3
• Prophylactic transfusion to increase oxygen-carrying capacity for wound healing is not indicated in asymptomatic normovolemic anemic patients with Hb > 6 g/dL without significant cardiovascular or pulmonary disease 3
• Mild to moderate anemia does not cause deleterious effects on wound healing, provided perfusion is maintained by adequate circulatory volume 3

When to Measure Hemoglobin

• Measure Hb before and after every unit of RBC transfused in patients without active bleeding 1
• In bleeding patients, Hb may remain falsely elevated despite significant blood loss due to inadequate fluid resuscitation 1
• Near-patient measurement of Hb may be useful, but laboratory measurement remains the gold standard 1

Additional Indications Beyond Hemoglobin Threshold

Consider transfusion when there are clinical signs and biochemical markers of inadequate oxygen delivery:

• Elevated blood lactate concentration 1
• Low pH (acidosis) 1
• Low central or mixed venous oxygen saturation 1

Common Pitfalls to Avoid

• Do not transfuse prophylactically to achieve arbitrary Hb targets (e.g., Hb ≥ 10 g/dL) for the purpose of improving graft take—this practice is not evidence-based and exposes patients to unnecessary transfusion risks 3
• Do not rely solely on Hb concentration in actively bleeding patients, as it may not reflect true blood loss until adequate fluid resuscitation occurs 1
• Do not forget that transfusion carries risks of both infectious and noninfectious complications, with noninfectious serious hazards being more common than transfusion-related infections 2

Managing Blood Loss at Donor Sites

Blood loss from split-thickness skin graft donor sites can be significant but is typically managed with topical hemostatic agents rather than transfusion:

• Topical agents including thrombin and epinephrine solutions effectively decrease donor site blood loss 4
• K-Y jelly/epinephrine mixtures serve as both dermatome lubricant and hemostatic agent, producing rapid hemostasis 4